New Designations Set To Speed Hemlibra, CAR-T In China
RSV Antiviral Also Benefits
Executive Summary
China is set to grant priority reviews to major biologics from Roche, the first CAR-T therapy from Wuxi Juno, and breakthrough therapy designation to a pediatric respiratory antiviral from ArkBio.